BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Feb. 28, 2008
View Archived Issues
FDA Pledges Renewed Focus to Boost Post-Market Safety
More than 100 years after the creation of the FDA, the agency said it now will apply the same standards it uses in its premarket drug reviews to manage its post-marketing safety process. (BioWorld Today)
Read More
Regeneron Gets FDA's OK for Arcalyst in CAPS
Read More
New Connections of Clotting to Inflammation in Sepsis, MS
Read More
NewCo News: Profectus Seeks a Bio Niche Hitting HIV from all Angles
Read More
Biogen, Elan Nicked on Reports of Tysabri-Linked Liver Injuries
Read More
RegeneRx Secures $5M for Wound Healing Trials
Read More
Receptor Logic Finds Partner to Develop T-Cell Mimics
Read More
Other News To Note
Read More
Earnings Roundup
Read More
Clinic Roundup
Read More